Form4.ai tracks every SEC insider trade in real time. See every BLSM insider filing with a free account — no card.
See every BLSM insider filing — free account, no card.
Free accountBlossomHill Therapeutics, Inc. (BLSM) has 11 SEC Form 4 insider filings on record in the last 90 days. That includes 6 insider purchases totalling $25.2M. Most recent filing: Aug. 12, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Aug 12, 2026 SEC filing | GORDON CARL L Director Same trade as ORBIMED ADVISORS LLC | Bought | $10,000,000 | +37.5% 30D |
| Aug 10, 2026 SEC filing | Schmid John P. Director | Bought | $96,000 | +37.5% 30D |
| Aug 10, 2026 SEC filing | Chen Bihua Director | Bought | $5,000,000 | +37.5% 30D |
Create a free account to see all 11 BLSM filings from the last 90 days. No card needed.
Create free accountWant BLSM insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.